The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier
Abstract
Abstract Lipid nanocarriers are developed as an alternative to polymeric nanoparticles, liposomes and emulsions. Further, Nanostructured Lipid Nanocarriers are the second generation lipid carriers developed to overcome problems associated with Solid Lipid Nanoparticles and are utilized in various therapeutic approaches. NLCs were primarily considered for the delivery of lipophilic drugs but their suitability for hydrophilic drugs is now well established. Biocompatible nature of lipids is responsible for its development as a promising drug delivery. It was found to be having superior characteristics over other lipid formulations. This article describes the NLC with respect to structures, methods of preparation, characterization, stability and its advantages over first generation lipid nanoparticles. Review mainly focuses on the various therapeutic applications of NLCs and their specificity for different physiological proximities. Due to their biologically non-toxic, non-immunogenic and compatible nature, NLCs are going to be the widely explored lipid nanocarrier systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Das, S., Ng, W. K., & Tan, R. B. H. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.05.010 · Cited by 576
Weber, S., Zimmer, A., & Pardeike, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.013 · Cited by 568
Nanostructured lipid carriers system: Recent advances in drug delivery
Iqbal, M. A., Md, S., Sahni, J. K., Baboota, S., Dang, S., & Ali, J. (2012) · Journal of Drug Targeting · doi:10.3109/1061186x.2012.716845 · Cited by 436
Doktorovova, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
Fang, C.-L., A. Al-Suwayeh, S., & Fang, J.-Y. (2013) · Recent Patents on Nanotechnology · doi:10.2174/187221013804484827 · Cited by 367
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Doktorovová, S., Kovačević, A. B., Garcia, M. L., & Souto, E. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.001 · Cited by 293
Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals
Puglia, C., & Bonina, F. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.666967 · Cited by 253
Teixeira, M. C., Carbone, C., & Souto, E. B. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.07.001 · Cited by 228
Shah, N. V., Seth, A. K., Balaraman, R., Aundhia, C. J., Maheshwari, R. A., & Parmar, G. R. (2016) · Journal of Advanced Research · doi:10.1016/j.jare.2016.03.002 · Cited by 223
Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib
Joshi, M., & Patravale, V. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600814676 · Cited by 213
Shidhaye, S., Vaidya, R., Sutar, S., Patwardhan, A., & Kadam, V. (2008) · Current Drug Delivery · doi:10.2174/156720108785915087 · Cited by 210
Selvaraj, K., Gowthamarajan, K., & Karri, V. V. S. R. (2017) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2017.1420073 · Cited by 210
Narang, J., Khan, S., Baboota, S., Ali, J., Khan, S., & Narang, R. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.167661 · Cited by 202
Balguri, S. P., Adelli, G. R., & Majumdar, S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.015 · Cited by 195
Sánchez-López, E., Espina, M., Doktorovova, S., Souto, E. B., & García, M. L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.013 · Cited by 185
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery
Gonzalez-Mira, E., Egea, M. A., Souto, E. B., Calpena, A. C., & García, M. L. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/4/045101 · Cited by 180
Sánchez-López, E., Espina, M., Doktorovova, S., Souto, E. B., & García, M. L. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.009 · Cited by 172
Araújo, J., Nikolic, S., Egea, M. A., Souto, E. B., & Garcia, M. L. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.06.025 · Cited by 171
Optimization of artemether-loaded NLC for intranasal delivery using central composite design
Jain, K., Sood, S., & Gowthamarajan, K. (2015) · Drug Delivery · doi:10.3109/10717544.2014.885999 · Cited by 158
Elmowafy, M., Ibrahim, H. M., Ahmed, M. A., Shalaby, K., Salama, A., & Hefesha, H. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1337823 · Cited by 150
Nanostructured lipid carriers: A potential use for skin drug delivery systems
Czajkowska-Kośnik, A., Szekalska, M., & Winnicka, K. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.10.008 · Cited by 150
Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease
Hernando, S., Herrán, E., Figueiro‐Silva, J., Pedraz, J. L., Igartúa, M., Carro, E., & Hernández, R. M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0728-7 · Cited by 142
Alam, T., Pandit, J., Vohora, D., Aqil, M., Ali, A., & Sultana, Y. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.945416 · Cited by 138
Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
Shamma, R. N., & Aburahma, M. H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s73010 · Cited by 127
Wu, M., Fan, Y., Lv, S., Xiao, B., Ye, M., & Zhu, X. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1058434 · Cited by 126
Chen, Y., Pan, L., Jiang, M., Li, D., & Jin, L. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1049719 · Cited by 122
Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review
Kulkarni, A. D., Vanjari, Y. H., Sancheti, K. H., Belgamwar, V. S., Surana, S. J., & Pardeshi, C. V. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1020809 · Cited by 120
Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion
Loo, Basri, M., Ismail, I., Lau, Tejo, B. A., Kanthimathi, M. S., Hassan, & Choo (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s35648 · Cited by 120
Lipid-based nanocarriers for breast cancer treatment – comprehensive review
Talluri, S. V., Kuppusamy, G., Karri, V. V. S. R., Tummala, S., & Madhunapantula, S. V. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1092183 · Cited by 117
Silva, A. C., Amaral, M. H., Lobo, J. M. S., & Tichota, D. M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s64008 · Cited by 109
Liu, Y., Wang, L., Zhao, Y., He, M., Zhang, X., Niu, M., & Feng, N. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.052 · Cited by 108
Liu, R., Liu, Z., Zhang, C., & Zhang, B. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23251 · Cited by 107
Carbone, C., Martins‐Gomes, C., Caddeo, C., Silva, A. M., Musumeci, T., Pignatello, R., Puglisi, G., & Souto, E. B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.064 · Cited by 106
Rizwanullah, M., Amin, S., & Ahmad, J. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1191080 · Cited by 104
Formulation and delivery of itraconazole to the brain using a nanolipid carrier system
Lim, W., RAJINIKANTH, P. S., Mallikarjun, C., & KANG, Y. B. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s57565 · Cited by 103
Li, J., Liu, D., Tan, G., et al. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.03.079 · Cited by 103
Rivastigmine-loadedin situgelling nanostructured lipid carriers for nose to brain delivery
Wavikar, P., & Vavia, P. R. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.954129 · Cited by 94
Pokharkar, V., Patil-Gadhe, A., & Palla, P. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.067 · Cited by 93
Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin
Shangguan, M., Lü, Y., Qi, J., Han, J., Tian, Z., Xie, Y., Hu, F., Yuan, H., & Wu, W. (2013) · Journal of Biomaterials Applications · doi:10.1177/0885328213485141 · Cited by 89
Vieira, A. C. C., Magalhães, J., Rocha, S., Cardoso, M. S., Santos, S. G., Borges, M. C., Pinheiro, M., & Reis, S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0248 · Cited by 89
Fu, T., Yi, J., Lv, S., & Zhang, B. (2016) · Journal of Liposome Research · doi:10.1080/08982104.2016.1224899 · Cited by 88
Pereira, I., Zielińska, A., Ferreira, N. R., Silva, A. M., & Souto, E. B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.068 · Cited by 86
Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B
Tan, S. L. J., Roberts, C. J., & Billa, N. (2018) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2018.1515225 · Cited by 86
Jiang, H., Geng, D., Liu, H., Li, Z., & Cao, J. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1217954 · Cited by 83
Li, X., Jia, X., & Hu, N. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s163929 · Cited by 80
Zhang, K., Lv, Li, Feng, Li, Liu, Li, & Li (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s45031 · Cited by 74
PEGylated nanostructured lipid carriers (PEG–NLC) as a novel drug delivery system for biochanin A
Wang, L., Luo, Q., Lin, T., Li, R., Zhu, T., Zhou, K., Ji, Z., Song, J.-W., Jia, B., Zhang, C., et al. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.938082 · Cited by 74
Balguri, S. P., Adelli, G. R., Janga, K. Y., Bhagav, P., & Majumdar, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.042 · Cited by 72
Guo, T., Zhang, Y., Zhao, J., Zhu, C., & Feng, N. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0107-3 · Cited by 71
Emami, J., Rezazadeh, M., Sadeghi, H., & Khadivar, K. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1189933 · Cited by 70
Pharmaceutical and Biomedical Applications of lipid-based Nanocarriers
Carbone, C., Leonardi, A., Cupri, S., Puglisi, G., & Pignatello, R. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.13.79 · Cited by 69
Zhang, B., Zhang, Y., & Yu, D. (2016) · Oncology Reports · doi:10.3892/or.2016.5298 · Cited by 69
Pardeike, J., Weber, S., Zarfl, H. P., Pagitz, M., & Zimmer, A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.018 · Cited by 68
Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy
Han, Y., Li, Y., Zhang, P., Sun, J., Li, X., Sun, X., & Kong, F. (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.996900 · Cited by 66
Nanostructure-based drug delivery systems for brain targeting
Haque, S., Md, S., Alam, M. I., Sahni, J. K., Ali, J., & Baboota, S. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.608191 · Cited by 66
Lipid Nanocarriers (LNC) and their Applications in Ocular Drug Delivery
Puglia, C., Offerta, A., Carbone, C., Bonina, F. P., Pignatello, R., & Puglisi, G. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209152259 · Cited by 64
Sabzichi, M., Mohammadian, J., Mohammadi, M., Jahanfar, F., Pour, A. A. M., Hamishehkar, H., & Ostadrahimi, A. (2017) · Nutrition and Cancer · doi:10.1080/01635581.2017.1339820 · Cited by 63
Brain-Targeted Drug Delivery: Experiences to Date
Bodor, N. S., & Buchwald, P. (2003) · American Journal of Drug Delivery · doi:10.2165/00137696-200301010-00002 · Cited by 62
Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
El-Helw, A.-R., & Fahmy, U. A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s91556 · Cited by 62
Kawadkar, J., Pathak, A., Kishore, R., & Chauhan, M. K. (2012) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.686509 · Cited by 61
Beloqui, A., Solinís, M. Á., Delgado, A., Évora, C., Isla, A., & Rodríguez‐Gascón, A. (2013) · Journal of Microencapsulation · doi:10.3109/02652048.2013.788090 · Cited by 60
Piran, P., Kafil, H. S., Ghanbarzadeh, S., Safdari, R., & Hamishehkar, H. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.031 · Cited by 60
Khan, S., Yar, M. S., Fazil, M., Hassan, M. Q., Baboota, S., & Ali, J. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.011 · Cited by 58
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery
Puglia, C., Blasi, P., Ostacolo, C., Sommella, E., Bucolo, C., Platania, C. B. M., Romano, G. L., Geraci, F., Drago, F., Santonocito, D., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00285 · Cited by 57
Brugè, F., Damiani, E., Marcheggiani, F., Offerta, A., Puglia, C., & Tiano, L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.033 · Cited by 56
Tian, B., Luo, Q., Song, S., Liu, D., Pan, H., Zhang, W., He, L., Shi-lin, M., Yang, X., & Pan, W. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22813 · Cited by 55
Voriconazole-Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery
Andrade, L. M., Rocha, K. A. D., de Sá, F. A. P., Marreto, R. N., Lima, E. M., Gratieri, T., & Taveira, S. F. (2016) · Cornea · doi:10.1097/ico.0000000000000825 · Cited by 54
Tian, C., Asghar, S., Wu, Y., Amerigos, D. K., Chen, Z., Zhang, M., Yin, L., Huang, L., Ping, Q., & Xiao, Y. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1391890 · Cited by 52
Godugu, C., Doddapaneni, R., Safe, S. H., & Singh, M. S. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.08.006 · Cited by 47
Carbone, C., Campisi, A., Manno, D. E., Serra, A., Spatuzza, M., Musumeci, T., Bonfanti, R., & Puglisi, G. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.05.024 · Cited by 46
Zhang, W., Liu, J., Zhang, Q., Li, X., Yu, S., Yang, X., Kong, J., & Pan, W. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.05.030 · Cited by 46
A new concept for the treatment of atopic dermatitis: Silver–nanolipid complex (sNLC)
Keck, C. M., Anantaworasakul, P., Patel, M., Okonogi, S., Singh, K. K., Roessner, D., Scherrers, R., Schwabe, K., Rimpler, C., & Müller, R. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.044 · Cited by 44
Hommoss, G., Pyo, S. M., & Müller, R. H. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.009 · Cited by 37
Nayak, K., Katiyar, S. S., Kushwah, V., & Jain, S. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1379527 · Cited by 36
Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine
Aliasgharlou, L., Ghanbarzadeh, S., Azimi, H., Zarrintan, M. H., & Hamishehkar, H. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.072 · Cited by 35
Song, Y., Shi, Y., Zhang, L., Hu, H., Zhang, C., Yin, M., Zhang, X., & Sun, K. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0322 · Cited by 23
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands
Carbone, C., Arena, E., Pepe, V., Prezzavento, O., Cacciatore, I., Türkez, H., Marrazzo, A., Stefano, A. D., & Puglisi, G. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.04.016 · Cited by 21
Cited by
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Lipid Nanoparticles for Drug Delivery
Xu, L., Wang, X., Liu, Y., Yang, G., Falconer, R. J., & Zhao, C.-X. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100109 · Cited by 545
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Elmowafy, M., & Al-Sanea, M. M. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.07.015 · Cited by 382
Lipid Nanoparticles as Carriers for Bioactive Delivery
Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.580118 · Cited by 345
Metadata
- Authors
- Salvi, V. R., & Pawar, P.
- Venue
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 51
- Pages
- 255-267
- ISSN
- 1773-2247 (ISSN-L)
- OpenAlex
- W2915230328
- Cited by
- 456
- References
- 84
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.